Volume 85 Issue 49 | pp. 42-43 | Meetings
Issue Date: December 3, 2007

Personalized Medicine Pow-wow

Pioneers in genetics-based therapies discuss the evidence for industry's evolution
Department: ACS News

The 3rd Annual Burrill Personalized Medicine Meeting, hosted in San Francisco last month by the life sciences investment firm Burrill & Co., brought together biopharmaceutical researchers for a two-day discussion of the future of health care—a future that is already beginning to manifest itself in the way that drugs are discovered, developed, and delivered to patients.

Though somewhat nebulous, the term "personalized medicine" is generally understood to describe the practice of . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society